Glucose metabolism and cell death in cancer
癌症中的葡萄糖代谢和细胞死亡
基本信息
- 批准号:7753198
- 负责人:
- 金额:$ 29.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectApoptoticAtrophicAttenuatedAutophagocytosisB-LymphocytesBax proteinCell DeathCell LineCell SurvivalCellsCessation of lifeCharacteristicsDependenceDependencyDigestionDown-RegulationFamilyFamily memberGlucoseGlucose TransporterGlycogen Synthase KinasesGrowth FactorHematopoieticHydrolysisLeukemic CellLymphoidLymphoid CellMalignant NeoplasmsMediatingMetabolicMetabolic PathwayMetabolismMitochondriaMyelogenousNatureNeoplasmsNutrientOncogenicPathway interactionsPentosephosphate PathwayPhosphorylationPhosphotransferasesPlayProcessProtein IsoformsProtein Kinase CProteinsRegulationResearch PersonnelResistanceRoleSignal PathwaySignal TransductionSourceSupporting CellTestingWithdrawalbasecancer cellcytokinedeprivationglucose metabolismhexokinaseinorganic phosphatemembermitochondrial autophagynovelpreventprogramstumor progression
项目摘要
A key barrier that leukemic cells overcome in cancer progression is dependence on cytokine growth
factors for survival. We have shown that prior to commitment to cell death, growth factor-deprivation of
normal lymphoid cells results in cellular atrophy with decreased glucose metabolism, activation of
autophagy, and proteolytic degradation of the anti-apoptotic Bcl-2 family member, Mcl1. In contrast,
leukemic cells or cells with activated forms of the oncogenic kinase, Akt/PKB, resist atrophy and cell death,
are highly glycolytic, and maintain Mcl1 even in the absence of growth factors. The role of this increased
glucose metabolism is unknown. We show that increased glucose metabolism characteristic of cancer
activates an anti-apoptotic nutrient signaling pathway. This glucose-stimulated signaling pathway involves
inhibitory phosphorylation of glycogen synthase kinase-3ff//? (GSK3) by protein kinase C (PKC), which
prevents degradation of Mcl1. McM stabilization appears critical as enhanced glucose metabolism failed to
provide a survival advantage in Mel 1-deficient cells. The means by which glucose hydrolysis promotes PKC
activity and regulates of McM remain uncertain. Glucose metabolism is also required for oncogenic Akt to
prevent cell death in the absence of growth factor and the pentose phosphate pathway (PPP), in particular,
may be important. In contrast, we show that Bcl-xL supports growth factor-independent survival in the
absence of glucose and instead must rely on autophagy to both maintain mitochondrial metabolites and
attenuate cell death. We hypothesize that the increased glucose utilization of cancer cells initiates cell
metabolism and survival pathways that impact both mitochondrial and alternative cell death pathways and
may play important roles in cancer cell resistance to death. We propose to: (1) Identify the mechanism of
anti-apoptotic glucose-mediated signal transduction to activate PKC and stabilize McM; (2) Examine the role
of glucose metabolism in cells expressing oncogenic Akt to determine the role that the PPP or alternative
metabolic pathways play in regulation of Mcl1 and cell death; and (3) Establish the role of increased glucose
metabolism on autophagy as a source of cell metabolism and survival in cytokine withdrawal. These studies
will identify mechanisms by which cell metabolism may regulate cell death and how the highly glycolytic
nature of cancer cells may affect these pathways to better understand cancer cell survival
mechanisms.
白血病细胞在癌症进展中克服的一个关键障碍是依赖于细胞因子生长
生存的因素。我们已经证明,在细胞死亡之前,生长因子剥夺,
正常淋巴样细胞导致细胞萎缩,葡萄糖代谢降低,
自噬和抗凋亡Bcl-2家族成员Mcl 1的蛋白水解降解。与此相反,
白血病细胞或具有致癌激酶Akt/PKB活化形式的细胞抵抗萎缩和细胞死亡,
是高度糖酵解的,并且即使在没有生长因子的情况下也维持Mcl 1。这一作用增强了
葡萄糖代谢未知。我们发现癌症的葡萄糖代谢增加
激活抗凋亡营养信号通路。这种葡萄糖刺激的信号通路涉及
抑制糖原合成酶激酶-3ff//?蛋白激酶C(PKC),
防止Mcl 1的降解。由于葡萄糖代谢的增强未能
在Mel 1缺陷细胞中提供存活优势。葡萄糖水解促进PKC的途径
MCM的活性和调控机制尚不明确。葡萄糖代谢也是致癌Akt所必需的,
在缺乏生长因子和戊糖磷酸途径(PPP)的情况下防止细胞死亡,特别是,
可能很重要相反,我们发现Bcl-xL支持非生长因子依赖性生存。
缺乏葡萄糖,而是必须依赖自噬来维持线粒体代谢物,
减少细胞死亡。我们假设癌细胞对葡萄糖的利用增加,
影响线粒体和替代细胞死亡途径的代谢和存活途径,
可能在癌细胞抵抗死亡中起重要作用。我们建议:(1)确定
抗凋亡葡萄糖介导的信号转导,以激活PKC和稳定McM;(2)检查作用
表达致癌Akt的细胞中葡萄糖代谢的变化,以确定PPP或替代物
代谢途径在调节Mcl 1和细胞死亡中起作用;(3)建立葡萄糖增加的作用
在细胞因子撤出中,自噬作为细胞代谢和存活的来源。这些研究
将确定细胞代谢可能调节细胞死亡的机制,以及高度糖酵解的
癌细胞的性质可能会影响这些途径,以更好地了解癌细胞的生存
机制等
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey C. Rathmell其他文献
Metabolic and stress response adaptations in T cells to fever and physiological heat
T细胞对发热和生理性高温的代谢及应激反应适应性
- DOI:
10.1016/j.it.2025.01.007 - 发表时间:
2025-03-01 - 期刊:
- 影响因子:13.900
- 作者:
Benjamin A. Wilander;Jeffrey C. Rathmell - 通讯作者:
Jeffrey C. Rathmell
Lactate Utilization Provides a Metabolic Escape to Resist the Antileukemic Activity of BET Inhibition in Acute Myeloid Leukemia
- DOI:
10.1182/blood-2022-164701 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Andrew J. Monteith;Haley E. Ramsey;Dalton Greenwood;Maria P. Arrate;Londa Fuller;Agnieszka E. Gorska;Alexander J. Silver;Donovan J. Brown;Sarah D. Olmstead;Jackson Watke;Matthew J. Stubbs;Jeffrey C. Rathmell;Michael R. Savona - 通讯作者:
Michael R. Savona
Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody–STING agonist conjugates
用模块化白蛋白搭便车纳米抗体-STING 激动剂偶联物增强癌症免疫疗法
- DOI:
10.1038/s41551-025-01400-0 - 发表时间:
2025-06-11 - 期刊:
- 影响因子:26.600
- 作者:
Blaise R. Kimmel;Karan Arora;Neil C. Chada;Vijaya Bharti;Alexander J. Kwiatkowski;Jonah E. Finkelstein;Ann Hanna;Emily N. Arner;Taylor L. Sheehy;Lucinda E. Pastora;Jinming Yang;Hayden M. Pagendarm;Payton T. Stone;Ebony Hargrove-Wiley;Brandie C. Taylor;Lauren A. Hubert;Barbara M. Fingleton;Katherine N. Gibson-Corley;Jody C. May;John A. McLean;Jeffrey C. Rathmell;Ann Richmond;W. Kimryn Rathmell;Justin M. Balko;John T. Wilson - 通讯作者:
John T. Wilson
Metabolic programming and immune suppression in the tumor microenvironment
肿瘤微环境中的代谢重编程与免疫抑制
- DOI:
10.1016/j.ccell.2023.01.009 - 发表时间:
2023-03-13 - 期刊:
- 影响因子:44.500
- 作者:
Emily N. Arner;Jeffrey C. Rathmell - 通讯作者:
Jeffrey C. Rathmell
Neurons require glucose uptake and glycolysis emin vivo/em
神经元在体内需要葡萄糖摄取和糖酵解
- DOI:
10.1016/j.celrep.2023.112335 - 发表时间:
2023-04-25 - 期刊:
- 影响因子:6.900
- 作者:
Huihui Li;Caroline Guglielmetti;Yoshitaka J. Sei;Misha Zilberter;Lydia M. Le Page;Lauren Shields;Joyce Yang;Kevin Nguyen;Brice Tiret;Xiao Gao;Neal Bennett;Iris Lo;Talya L. Dayton;Martin Kampmann;Yadong Huang;Jeffrey C. Rathmell;Matthew Vander Heiden;Myriam M. Chaumeil;Ken Nakamura - 通讯作者:
Ken Nakamura
Jeffrey C. Rathmell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey C. Rathmell', 18)}}的其他基金
Metabolic barriers to T cell activation in clear cell renal cell carcinoma
透明细胞肾细胞癌中 T 细胞活化的代谢障碍
- 批准号:
10532599 - 财政年份:2018
- 资助金额:
$ 29.64万 - 项目类别:
Metabolic Barriers to T Cell Activation in Clear Cell Renal Cell Carcinoma
透明细胞肾细胞癌中 T 细胞激活的代谢障碍
- 批准号:
10375526 - 财政年份:2018
- 资助金额:
$ 29.64万 - 项目类别:
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
利用 CD4 T 细胞亚群的代谢脆弱性来控制炎症性疾病
- 批准号:
10380136 - 财政年份:2015
- 资助金额:
$ 29.64万 - 项目类别:
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
利用 CD4 T 细胞亚群的代谢脆弱性来控制炎症性疾病
- 批准号:
9269283 - 财政年份:2015
- 资助金额:
$ 29.64万 - 项目类别:
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
利用 CD4 T 细胞亚群的代谢脆弱性来控制炎症性疾病
- 批准号:
9889950 - 财政年份:2015
- 资助金额:
$ 29.64万 - 项目类别:
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
利用 CD4 T 细胞亚群的代谢脆弱性来控制炎症性疾病
- 批准号:
8890911 - 财政年份:2015
- 资助金额:
$ 29.64万 - 项目类别:
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
利用 CD4 T 细胞亚群的代谢脆弱性来控制炎症性疾病
- 批准号:
9126664 - 财政年份:2015
- 资助金额:
$ 29.64万 - 项目类别:
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
利用 CD4 T 细胞亚群的代谢脆弱性来控制炎症性疾病
- 批准号:
10586461 - 财政年份:2015
- 资助金额:
$ 29.64万 - 项目类别:
B cell metabolism in activation and autoantibody production
B 细胞代谢激活和自身抗体产生
- 批准号:
8561193 - 财政年份:2013
- 资助金额:
$ 29.64万 - 项目类别:
Glucose Transport in Regulation of T Cell Activation and Inflammation
葡萄糖转运在 T 细胞激活和炎症调节中的作用
- 批准号:
8513581 - 财政年份:2012
- 资助金额:
$ 29.64万 - 项目类别:
相似海外基金
Mechanisms that underlie the life/death decisions in a cell that activated apoptotic caspases
细胞中激活凋亡半胱天冬酶的生/死决策的机制
- 批准号:
10607815 - 财政年份:2023
- 资助金额:
$ 29.64万 - 项目类别:
Nuclear and chromatin aberrations during non-apoptotic cell death in C. elegans and mammals
线虫和哺乳动物非凋亡细胞死亡过程中的核和染色质畸变
- 批准号:
10723868 - 财政年份:2023
- 资助金额:
$ 29.64万 - 项目类别:
Non-apoptotic functions of caspase-3 in neural development
Caspase-3在神经发育中的非凋亡功能
- 批准号:
10862033 - 财政年份:2023
- 资助金额:
$ 29.64万 - 项目类别:
Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance
凋亡供体白细胞促进肾移植耐受
- 批准号:
10622209 - 财政年份:2023
- 资助金额:
$ 29.64万 - 项目类别:
Design of apoptotic cell mimetic anti-inflammatory polymers for the treatment of cytokine storm
用于治疗细胞因子风暴的模拟凋亡细胞抗炎聚合物的设计
- 批准号:
22H03963 - 财政年份:2022
- 资助金额:
$ 29.64万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identifying the mechanisms behind non-apoptotic functions of mitochondrial matrix-localized MCL-1
确定线粒体基质定位的 MCL-1 非凋亡功能背后的机制
- 批准号:
10537709 - 财政年份:2022
- 资助金额:
$ 29.64万 - 项目类别:
Activation of non-apoptotic cell death by the DNA damage response
DNA 损伤反应激活非凋亡细胞死亡
- 批准号:
10388929 - 财政年份:2022
- 资助金额:
$ 29.64万 - 项目类别:
Environmental Carcinogens Induce Minority MOMP to Initiate Carcinogenesis in Lung Cancer and Mesothelioma whileMaintaining Apoptotic Resistance via Mcl-1
环境致癌物诱导少数 MOMP 引发肺癌和间皮瘤的癌变,同时通过 Mcl-1 维持细胞凋亡抵抗
- 批准号:
10356565 - 财政年份:2022
- 资助金额:
$ 29.64万 - 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
- 批准号:
10708827 - 财政年份:2022
- 资助金额:
$ 29.64万 - 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
- 批准号:
10538071 - 财政年份:2022
- 资助金额:
$ 29.64万 - 项目类别: